In contrast to artificial sweeteners, there are no reported negative health consequences of Stevia, such as toxicity, teratogenicity, mutagenicity or carcinogenicity. In contrast, the anti-hyperglycemic, antioxidant and antihypertensive properties of stevioside have been well documented, suggesting a potential medicinal use as an adjunctive treatment for several diseases.
Anti-hyperglycemic PropertiesStevia glycosides have been widely shown to prevent weight gain and decrease serum glucose levels in animal and human models. As with any zero-calorie sweetener, stevia lacks calories and reduces serum glucose levels that typically rise about 1 hour after carbohydrate consumption, compared to sucrose. However, a 2010 study by Kujur et al. found that stevia significantly reduces mean serum glucose levels in subjects over a 1-month period. The study used Wister rats with diabetes induced by 5% alloxan monohydrate, and found that administering 50 mg/kg and 100 mg/kg of stevia daily resulted in significant time-dependent anti-hyperglycemic effects. When treated with 50 mg/kg of stevia in the aqueous, ether and methanolic extracts for 28 days, mean serum glucose levels fell from 220 to 161 mg/dL; 220 to 171 mg/dL; and 232to 163mg/dL, respectively. When treated with 100 mg/kg of the stevia extracts, mean serum glucose levels fell from 220 to 137 mg/dL; 209 to 168 mg/dL; and 218 to 181 mg/dL, respectively. There were non-significant differences in serum glucose levels between the 50mg/kg and 100mg/kg doses. Rats administered glyburide, a known oral diabetes medication that was used as a positive control, hada reduction in mean serum glucose levels from 211 to 101 mg/dL after 28 days. Thus, the administration of stevia